Now in open access, a debate about the necessity of spinal taps to diagnose IIH. It's no-one's favorite test, but the information gained is valuable! https://t.co/CjHgVc6Upq
While virtual talks are not as fun for the presenter - it's cool to be able to speak on the other side of the world! Thanks @clarefraser for including me in the @RANZCOeyedoctor Advances in Ophthalmology Event
2 of our articles are now available open access - follow the links to learn about ED utilization for acute optic neuritis and about the handheld pupillometer we programmed and validated:
https://t.co/qg1WON57dE
https://t.co/gAh46JaPBH
After 2 years of virtual offerings, we are celebrating two terrific days of in person neuro-ophth education at the Stanford Bay Area Ophthalmology Course 2022. @ByersEye @AndrewGoLeeMD1 @NailynRasool
In this study of 86 patients with IIH receiving venous sinus stents (VSS) (a collaboration with @chenmayo), we found VSS to be associated with improvement in papilledema. https://t.co/lt8Ecovm4B
Neuro-ophthalmologists are still using more telehealth than before COVID-19, but less than in early days. Always a pleasure to work with you @kevinelaimd and @MelissaKo16
https://t.co/eZ8jV1K9mb
Our @ByersEye QI project is published! Interventions Targeting Follow-up Appointment Scheduling After ED Referral to Ophthalmology Clinics https://t.co/q4ZDSN0rU7 via @JAMAOphth part of @JAMANetwork
Hot off the press in @journalneurooph how are neuro-ophth patients different than glaucoma patients? how can we identify patients at risk of loss to follow up? Great work by @ReemAzizTweets https://t.co/EuSbVhsyNb
Need free CME? Want to watch @AndrewGoLeeMD1 @chenmayo and @HeatherMossMD banter about NMO? Have a free hour? Missed the live presentation at #NANOS2022? Check out: https://t.co/D6a9HEVRs7 @VindicoMedEd
Now available open access, our work with Steven Roth @uicovs building a predictive model for ischemic optic neuropathy in spinal fusion published in @TSJ_Editor https://t.co/6R7F93ISDe
A successful day at #NANOS2022 in Austin, Texas! Thank you to our panel for an outstanding discussion on the burden, diagnosis pathophysiology, and treatment of #NMOSD. @AndrewGoLeeMD1 @HeatherMossMD@chenmayo@NANOSTweets